Exact Sciences Announces Second Quarter 2025 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Grand Canyon Education places CFO on leave amid stock trade probe
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- Funds sell $44bn in semiconductors on AI concerns
Exact Sciences (EXAS) Tops Q2 EPS by 12c, Updates Guidance
August 6, 2025 4:12 PM EDTExact Sciences (NASDAQ: EXAS) reported Q2 EPS of ($0.01), $0.12 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $811.1 million versus the consensus estimate of $773.8 million.
GUIDANCE:
Exact Sciences sees FY2025 revenue of $3.13-3.17 billion, versus the consensus... More
